So how about $3.5 billion in 1st quarter sales, from a book of work that did not exist a year ago, with zero product liability.
Anyone else think that’s a pretty good deal?
And the Government bought it all, no bid, negotiated cost.
Pfizer’s COVID-19 vaccine earned the company $3.5 billion in the first three months of this year, representing nearly a quarter of its total revenue, the company announced ahead of its earnin…